Neurocrine Corp (NBIX) - Bozor qiymatining balans qiymatiga nisbati

Neurocrine (NBIX) - korporativ logo

Nerv tizimi buzilishlarini davolash nishasidagi ustunlik Neurocrine Biosciences (NBIX) kompaniyasining marjasini narxlarning pasayishidan himoya qiladi. Patentlangan formulalar barqaror talabni ta'minlab, yuqori rentabelli daromad generatorini yaratadi. Kasalliklarning surunkli tabiati uzoq amalga oshirish siklini kafolatlaydi. GURU.Markets grafigidagi kunlik dinamikada balans kapitalining qayta baholash darajasidagi o'zgarish joriy qiymat 3.99 ekanligini ko'rsatmoqda, bu esa sof aktivlarning bozor qiymatini aks ettiradi.

neurocrine.com (NBIX) - Bozor qiymatining balans qiymatiga koeffitsiyenti 04.07.2022dan 31.10.2026gacha
Neurocrine Biosciences Inc ishlab chiqargan mahsulot

Ushbu koeffitsiyent barcha aksiyalarning joriy bozor qiymatining sof aktivlar qiymatiga nisbatining kvotsienti sifatida hisoblanadi va investitsiya uchun haqiqiy xavfsiz boshpana chegarasini belgilaydi. Neurocrine Biosciences (NBIX) kompaniyasining narxning buki qiymatiga nisbatini tahlil qilish orqali investor narx korreksiyasi paytida kritik yo'qotishlarning oldini olish uchun kompaniyaning neurologiya sohasidagi yuqori ilmiy obro'si uchun haddan tashqari ko'p to'lash xavfini baholaydi.

Muhim raqobatchilar

BIIB (Biogen Inc.) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati RGC|Bozor qiymatining balans qiymatiga nisbati Axsome Therapeutics, Inc.|Kapitallashuvning balans qiymatiga nisbati ACAD (ACADIA Pharma)|Bozor kapitallashuvining balans qiymatiga nisbati XENE|VKTX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Supernus Pharmaceuticals - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati catalystpharma.com CPRX|DNLI - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati HRMY (Harmony Biosciences Inc)|Biohaven Pharmaceutical (BHVN) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Amylyx Corp (AMLX)|Bozor qiymatining balans qiymatiga nisbati Trevi Therapeutics|Kapitallashuvning balans qiymatiga nisbati PRAX (praxismedicines.com)|Bozor kapitallashuvining balans qiymatiga nisbati AVXL|CBLL - Bozor qiymatining balans qiymatiga koeffitsiyenti|prothena.com - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Alector Inc. ALEC|ANNX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati OMER (Omeros Corporation)|Neurogene (NGNE) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti AC Immune S.A. (ACIU)|VYGR (Voyager Pharma) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Neumora Corp (NMRA)|Bozor qiymatining balans qiymatiga nisbati Scilex Holding Company (SCLX)|TVGN (tevogen.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ACOG (Alpha Cognition Inc.)|Balans qiymatiga nisbatan bozor kapitallashuvi cogrx.com (CGTX)|IKT - Bozor qiymatining balans qiymatiga nisbati|SAVA (Cassava Pharma) - Kapitallashuvning balans qiymatiga nisbati|ASRT: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Coya Therapeutics (COYA)|Kapitallashuvning sof aktivlarga nisbati VTGN|OVID: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ABOS|Bozor qiymatining balans qiymatiga nisbati CRVO (CervoMed Corporation)|Bozor kapitallashuvining balans qiymatiga nisbati ATHE (Alterity Therapeutics Limited)|Balans qiymatiga nisbatan bozor kapitallashuvi Clene Inc (CLNN)|PEPG - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti jupiterneurosciences.com|Relmada (RLMD) - Bozor qiymatining balans qiymatiga nisbati|ANVS - Balans qiymatiga nisbatan bozor kapitallashuvi|GRCE (Grace Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati fireflyneuro.com (AIFF)|Bozor kapitallashuvining balans qiymatiga nisbati KLTO|Balans qiymatiga nisbatan bozor kapitallashuvi neurosense-tx.com|Bozor kapitallashuvining balans qiymatiga nisbati RVPH (Reviva Pharmaceuticals Holdings)|MetaVia Inc. (MTVA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|NRXS - Bozor qiymatining balans qiymatiga nisbati|HSDT (Helius Medical) - Kapitallashuvning balans qiymatiga nisbati|PASG: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Neuphoria Therapeutics|NERV (Minerva Neurosciences Corp) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Athira Pharma Corp ATHA|Bozor qiymatining balans qiymatiga nisbati Addex Therapeutics (ADXN)|Balans qiymatiga nisbatan bozor kapitallashuvi alzamend.com|Bozor qiymatining balans qiymatiga nisbati Cyclerion Therapeutics, Inc. CYCN|PTIX: Kapitallashuvning balans qiymatiga nisbati|Pasithea - Bozor kapitallashuvining balans qiymatiga nisbati|CRGT: Bozor qiymatining balans qiymatiga nisbati|ATXI: Bozor kapitallashuvining balans qiymatiga nisbati|BCLI - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati CARA|Kapitallashuvning balans qiymatiga nisbati CHRO (Chromocell Therapeutics Corp)|Bozor qiymatining balans qiymatiga nisbati Eliem Therapeutics (ELYM)|intracellulartherapies.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati LBPH (Longboard Pharmaceuticals)|marinuspharma.com (MRNS) - Bozor qiymatining balans qiymatiga koeffitsiyenti|NKGN: Kapitallashuvning sof aktivlarga nisbati|NRBO - Bozor kapitallashuvining balans qiymatiga nisbati|Sage Therapeutics, Inc (SAGE) - Bozor qiymatining balans qiymatiga nisbati|Synaptogenix, Inc - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Trevena, Inc.|Bozor qiymatining balans qiymatiga koeffitsiyenti Vigil Neuro VIGL|Bozor qiymatining balans qiymatiga nisbati Anew Medical, Inc. (WENA)|Cerevel Therapeutics Inc - Kapitallashuvning balans qiymatiga nisbati